#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17792	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2104	823.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1428	1428	C	1145	C	1022	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17792	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2104	823.5	0	HET	.	.	.	C326T	.	326	326	C	570	570	C	823	C,T	565,191	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	17792	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2104	823.5	0	HET	.	.	.	C207T	.	207	207	C	451	451	C	834	C,T	442,296	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32126	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3617	867.2	0	.	n	.	0	T695C	SNP	695	695	T	987	987	C	1209	C,G,A	1095,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32126	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3617	867.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1930	1930	G	840	G	755	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32126	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3617	867.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2263	2263	C	1042	C,T	941,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32126	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3617	867.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2337	2337	A	1144	A	1018	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32126	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3617	867.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2889	2889	C	978	C,G	846,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1304	folP	855	855	100.0	folP.l6.c4.ctg.1	1747	72.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1118	1120	AGC	137;138;139	A;G;C	125;126;126	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3142	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3269	92.4	1	SNP	p	S91F	1	.	.	271	273	TTC	537	539	TTC	120;119;120	T;T;C	113;113;113	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3142	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3269	92.4	1	SNP	p	D95G	1	.	.	283	285	GGC	549	551	GGC	126;130;130	G;G;C	119;124;124	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3142	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3269	92.4	1	SNP	p	G95N	0	.	.	283	285	GGC	549	551	GGC	126;130;130	G;G;C	119;124;124	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	914	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1310	67.3	1	SNP	p	G45D	0	.	.	133	135	GGC	496	498	GGC	121;123;123	G;G;C	113;116;115	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	666	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	868	73.0	0	.	n	.	0	A197.	DEL	197	197	A	504	504	A	155	A	148	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2688	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2814	91.8	1	SNP	p	D86N	0	.	.	256	258	GAC	489	491	GAC	126;126;128	G;A;C	118;115;121	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2688	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2814	91.8	1	SNP	p	S87R	1	.	.	259	261	CGT	492	494	CGT	128;128;129	C;G;T	121;119;120	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2688	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2814	91.8	1	SNP	p	R87W	0	.	.	259	261	CGT	492	494	CGT	128;128;129	C;G;T	121;119;120	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2688	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2814	91.8	1	SNP	p	R87I	0	.	.	259	261	CGT	492	494	CGT	128;128;129	C;G;T	121;119;120	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2688	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2814	91.8	1	SNP	p	S88P	0	.	.	262	264	TCC	495	497	TCC	129;133;132	T;C;C	119;125;125	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2540	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2716	89.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1551	1553	GGC	75;75;75	G;G;C	68;70;66	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3214	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2183	143.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1186	1188	GCC	224;224;224	G;C;C	198;199;198	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3214	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2183	143.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1189	1191	ATG	208;201;200	A;T,G;G,C	186;180,1;179,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3214	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2183	143.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1201	1203	ACC	229;228;220	A;C,T;C	201;205,1;198	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3214	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2183	143.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1201	1203	ACC	229;228;220	A;C,T;C	201;205,1;198	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3214	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2183	143.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1702	1704	ACC	135;136;132	A;C;C	128;130;126	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3214	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2183	143.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1756	1758	GCG	104;105;107	G;C;G	98;98;102	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3214	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2183	143.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1756	1758	GCG	104;105;107	G;C;G	98;98;102	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3214	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2183	143.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1879	1881	GGT	86;86;84	G;G;T	86;86;84	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3214	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2183	143.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1888	1890	AGC	74;74;73	A;G;C	74;74;73	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3214	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2183	143.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1906	1908	CCG	38;33;33	C;C;G	38;32;33	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5372	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2904	177.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1523	1525	CCG	87;86;86	C;C;G	87;86;82	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1254	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1836	66.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	596	596	C	66	C	63	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	184	porB1a	984	264	90.3	porB1a.l15.c4.ctg.2	355	19.8	0	.	p	.	0	H217N	NONSYN	649	651	CAT	116	118	AAT	14;14;14	A;A;T	13;14;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	184	porB1a	984	264	90.3	porB1a.l15.c4.ctg.2	355	19.8	0	.	p	.	0	D218N	NONSYN	652	654	GAT	119	121	AAT	14;14;14	A;A;T	14;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	184	porB1a	984	264	90.3	porB1a.l15.c4.ctg.2	355	19.8	0	.	p	.	0	V226A	NONSYN	676	678	GTA	143	145	GCA	13;13;12	G,A;C;A	11,1;12;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	184	porB1a	984	264	90.3	porB1a.l15.c4.ctg.2	355	19.8	0	.	p	.	0	.	MULTIPLE	700	702	ACT	166	168	GTA	13;13;13	G;T,G;A	13;12,1;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	184	porB1a	984	264	90.3	porB1a.l15.c4.ctg.2	355	19.8	0	.	p	.	0	N237fs	FSHIFT	709	709	A	175	175	A	14	A	14	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2266	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1684	130.1	1	SNP	p	G120K	1	.	.	358	360	AAG	734	736	AAG	177;176;178	A;A;G	159;159;159	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2266	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1684	130.1	1	SNP	p	N121D	0	.	.	361	363	AAC	737	739	AAC	177;176;181	A;A;C	160;160;163	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2266	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1684	130.1	1	SNP	p	A121N	1	.	.	361	363	AAC	737	739	AAC	177;176;181	A;A;C	160;160;163	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7954	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4632	167.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	774	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1126	67.5	1	SNP	p	V57M	1	.	.	169	171	ATG	545	547	ATG	152;154;155	A,T;T;G	132,1;136;136	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
